IP Verse

Moderna competitive analysis

Latest publications and patents of Moderna New

Explore the latest publications and patents granted to Moderna, showcasing their recent innovations and technological advancements.

Last updated on: Sep 18, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Moderna

EP4594334
Aug 6, 2025Purification Of Nucleotides By Means Of A Mixed-Mode Purification SystemPending
EP4577519
Jul 2, 2025Methods For Purification Of Ionizable LipidsPending
EP4565694
Jun 11, 2025Extraction-Less Reverse Phase (Rp) Chromatography For Mrna Purity AssessmentPending
EP4565692
Jun 11, 2025Internal Ribosome Entry Sites For Improved Polynucleotide TranslationPending
EP4562163
Jun 4, 2025Engineered Polynucleotides For Temporal Control Of ExpressionPending
EP4562141
Jun 4, 2025Methods Of Rna PurificationPending
EP4561638
Jun 4, 2025Engineered Polynucleotides For Cell Selective ExpressionPending
EP4561547
Jun 4, 2025Lipid Nanoparticle Compositions Comprising Phospholipid Derivatives And Related UsesPending
EP4561546
Jun 4, 2025Lipid Nanoparticle Compositions Comprising Surface Lipid Derivatives And Related UsesPending
EP4554617
May 21, 2025Norovirus Mrna VaccinesPending

Latest oppositions filed by Moderna

Explore patent oppositions filed by Moderna against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Sep 25, 2025
Patent NumberTitleApplicantOpposition Date

Get instant updates on new opposition filings by the company

EP4226941
Pegylated Liposomes For Delivery Of Immunogen-Encoding RnaGLAXOSMITHKLINEJul 15, 2025
EP4241767
Novel Lipids And Compositions For The Delivery Of TherapeuticsARBUTUS BIOPHARMAApr 29, 2025
EP3115064
Rna-Coded AntibodyCUREVACAug 24, 2022
EP2958588
Combination Of Vaccination And Inhibition Of The Pd-1 PathwayCUREVACMay 22, 2018
EP2279254
Novel Lipid Formulations For Nucleic Acid DeliveryARBUTUS BIOPHARMAApr 5, 2018

Latest patents of Moderna opposed by its competitors

Explore Moderna's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3394030
Feb 12, 2025Compounds And Compositions For Intracellular Delivery Of Agents1
EP4108671
Nov 20, 2024Modified Nucleosides, Nucleotides, And Nucleic Acids, And Uses Thereof6
EP3981437
Oct 9, 2024Nucleic Acid Vaccines4
EP4023249
Oct 9, 2024Nucleic Acid Vaccines3
EP3853305
Oct 2, 2024High-Purity Peg Lipids And Uses Thereof6
EP3431485
Sep 4, 2024Engineered Nucleic Acids And Methods Of Use Thereof2
EP3917503
May 8, 2024Methods Of Preparing Lipid Nanoparticles1
EP3359670
Feb 14, 2024Methods For Therapeutic Administration Of Messenger Ribonucleic Acid Drugs1
EP3578652
Jul 12, 2023Ribonucleic Acid Purification1
EP3625345
May 24, 2023Modified Messenger Rna Comprising Functional Rna Elements2

Latest PTAB cases involving Moderna

Discover the latest PTAB cases involving Moderna, highlighting their recent legal challenges and patent disputes.

Last updated on: Sep 24, 2025
Proceeding NumberFiling DatePetitionerRespondentStatus

Get alerts for PTAB Cases involving Moderna

IPR2023-01359Aug 28, 2023BIONTECHMODERNAFinal Written Decision - Appealed
IPR2023-01358Aug 28, 2023PFIZERMODERNAFinal Written Decision - Appealed
IPR2019-00554Jan 9, 2019MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00739Mar 5, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2018-00680Feb 21, 2018MODERNAARBUTUS BIOPHARMAFinal Written Decision
IPR2017-02194Sep 29, 2017MODERNACUREVACFinal Written Decision

Peer Comparison New

IP litigation analysis comparing Moderna with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
MODERNA57442Defensive
ARBUTUS BIOPHARMA - 6 - 3Non-Active
BIONTECH3061 - Highly Aggressive
MAIWALD132 - - - Highly Aggressive